![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
.jpg)
Patient Report and Disability in Peripheral Artery Disease
This Viewpoint discusses discordance between patient report and objectively measured walking impairment in people with peripheral artery disease without critical leg ischemia and how this discordance affects clinical care and scientific investigation.
This Viewpoint discusses discordance between patient report and objectively measured walking impairment in people with peripheral artery disease without critical leg ischemia and how this discordance affects clinical care and scientific investigation.
